Nutrients 2011, 3(1), 49-62; doi:10.3390/nu3010049
Article

Folate Status of Reproductive Age Women and Neural Tube Defect Risk: The Effect of Long-Term Folic Acid Supplementation at Doses of 140 µg and 400 µg per Day

1 Department of Human Nutrition, University of Otago, Dunedin 9054, New Zealand 2 Department of Preventive and Social Medicine, University of Otago, Dunedin 9054, New Zealand
* Author to whom correspondence should be addressed.
Received: 22 November 2010; in revised form: 13 December 2010 / Accepted: 7 January 2011 / Published: 10 January 2011
(This article belongs to the Special Issue Folate Metabolism and Nutrition)
PDF Full-text Download PDF Full-Text [216 KB, uploaded 10 January 2011 14:51 CET]
Abstract: Primary prevention of most folate-responsive neural tube defects (NTDs) may not require 400 μg folic acid/day but may be achieved by attaining a high maternal folate status. Using RBC folate ≥ 906 nmol/L as a marker for NTD risk reduction, the study aimed to determine the change in blood folate concentrations in reproductive age women in response to long-term folic acid supplementation at 400 µg/day and 140 µg/day (dose designed to mimic the average daily folic acid intake received from New Zealand’s proposed mandatory bread fortification program). Participants were randomly assigned to a daily folic acid supplement of 140 µg (n = 49), 400 µg (n = 48) or placebo (n = 47) for 40 weeks. RBC folate concentrations were measured at baseline, and after 6, 12, 29 and 40 weeks. At 40 weeks, the overall prevalence of having a RBC folate < 906 nmol/L decreased to 18% and 35% in the 400 µg and 140 µg groups, respectively, while remaining relatively unchanged at 58% in the placebo group. After 40 weeks, there was no evidence of a difference in RBC folate between the two treatment groups (P = 0.340), nor was there evidence of a difference in the odds of a RBC folate < 906 nmol/L (P = 0.078). In conclusion, the average daily intake of folic acid received from the proposed fortification program would increase RBC folate concentrations in reproductive age women to levels associated with a low risk of NTDs.
Keywords: neural tube defects; blood folate status; folic acid fortification; supplementation

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Hursthouse, N.A.; Gray, A.R.; Miller, J.C.; Rose, M.C.; Houghton, L.A. Folate Status of Reproductive Age Women and Neural Tube Defect Risk: The Effect of Long-Term Folic Acid Supplementation at Doses of 140 µg and 400 µg per Day. Nutrients 2011, 3, 49-62.

AMA Style

Hursthouse NA, Gray AR, Miller JC, Rose MC, Houghton LA. Folate Status of Reproductive Age Women and Neural Tube Defect Risk: The Effect of Long-Term Folic Acid Supplementation at Doses of 140 µg and 400 µg per Day. Nutrients. 2011; 3(1):49-62.

Chicago/Turabian Style

Hursthouse, Nicola A.; Gray, Andrew R.; Miller, Jody C.; Rose, Meredith C.; Houghton, Lisa A. 2011. "Folate Status of Reproductive Age Women and Neural Tube Defect Risk: The Effect of Long-Term Folic Acid Supplementation at Doses of 140 µg and 400 µg per Day." Nutrients 3, no. 1: 49-62.

Nutrients EISSN 2072-6643 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert